Skip to main content
Journal ArticleOPEN ACCESS

Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis

  • Kamath S
  • Kumthekar P
  • Kruser T
  • et al.
The Oncologist (2018) 23(12) e159-e161
DOI: 10.1634/theoncologist.2018-0022
6Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Central nervous system metastasis in non-small cell lung cancer remains a therapeutic challenge and confers a poor prognosis. Here we describe a patient with lung adenocarcinoma, parenchymal brain metastases, and leptomeningeal carcinomatosis who demonstrated a sustained response to programmed death 1 inhibition combined with stereotactic radiosurgery.

Cite

CITATION STYLE

APA

Kamath, S. D., Kumthekar, P. U., Kruser, T. J., & Mohindra, N. A. (2018). Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis. The Oncologist, 23(12), e159–e161. https://doi.org/10.1634/theoncologist.2018-0022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free